[1] SIEGAL D,KELLER A,XU W,et al.Central nervous system complications after allogeneic hematopoietic stem cell transplantation:incidence,manifestations,and clinical significance[J].Biol Blood Marrow Transplant,2007,13(11):1369-1379.
[2] UCKAN D,CETIN M,YIGITKANLI I,et al.Life-threatening neurological complications after bone marrow transplantation in children[J].Bone Marrow Transplant,2005,35(1):71-76.
[3] SAIZ A,GRAUS F.Neurological complications of hematopoietic cell transplantation[J].Semin Neurol,2004,24(4):427-434.
[4] SOSTAK P,PADOVAN C S,YOUSRY T A,et al.Prospective evaluation of neurological complications after allogeneic bone marrow transplantation[J].Neurology,2003,60(5):842-848.
[5] KISHI Y,MIYAKOSHI S,KAMI M,et al.Early central nervous system complications after reduced-intensity stem cell transplantation[J].Biol Blood Marrow Transplant,2004,10(8):561-568.
[6] AVIVI I,CHAKRABARTI S,KOTTARIDIS P,et al.Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation[J].Bone Marrow Transplant,2004,34(2):137-142.
[7] BLEGGI-TORRES L F,de MEDEIROS B C,WERNER B,et al.Neuropathological findings after bone marrow transplantation:an autopsy study of 180 cases[J].Bone Marrow Transplant,2000,25(3):301-307.
[8] BATLLE M,ORIOL A,RIBERA J M,et al.Neurologic complications following hematopoietic stem cell transplantation.Study of 14 patients[J].Med Clin (Barc),2005,125(18):697-699.
[9] WEBER C,SCHAPER J,TIBUSSEK D,et al.Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation[J].Bone Marrow Transplant,2008,41(3):253-259.
[10] UCKAN D,CETIN M,YIGITKANLI I,et al.Life-threatening neurological complications after bone marrow transplantation in children[J].Bone Marrow Transplant,2005,35(1):71-76.
[11] CHEN B T,ORTIZ A O,DAGIS A,et al.Brain imaging findings in symptomatic patients after allogeneic haematopoietic stem cell transplantation:correlation with clinical outcome[J].Eur Radiol,2012,22(10):2273-2281.
[12] JONES D,VICHAYA E G,WANG X S,et al.Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant[J].Cancer,2013,119(23):4188-4195.
[13] SYRJALA K L,DIKMEN S,LANGER S L,et al.Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant[J].Blood,2004,104(10):3386-3392.
[14] CORREA D D,ROOT J C,BASER R,et al.A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients[J].Brain Imaging Behav,2013,7(4):478-490.
[15] FANN J R,HUBBARD R A,ALFANO C M,et al.Pre-and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation[J].J Clin Oncol,2011,29(7):895-901.
[16] BEGLINGER L J,DUFF K,van der HEIDEN S,et al.Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients[J].Biol Blood Marrow Transplant,2006,12(9):928-935.
[17] WECKMANN M T,GINGRICH R,MILLS J A,et al.Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation[J].Ann Clin Psychiatry,2012,24(3):204-214.
[18] SIOKA C,KYRITSIS A P.Central and peripheral nervous system toxicity of common chemotherapeutic agents[J].Cancer Chemother Pharmacol,2009,63(5):761-767.
[19] DIETRICH J,HAN R,YANG Y,et al.CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo[J].J Biol,2006,5(7):22.
[20] TESFAYE H,BRANOVA R,KLAPKOVA E,et al.The importance of Therapeutic Drug Monitoring (TDM) for parenteral busulfan dosing in conditioning regimen for Hematopoietic Stem Cell Transplantation (HSCT) in children[J].Ann Transplant,2014,19:214-224.
[21] PATEL R S,RACHAMALLA M,CHARY N R,et al.Cytarabine induced cerebellar neuronal damage in juvenile rat:correlating neurobehavioral performance with cellular and genetic alterations[J].Toxicology,2012,293(1-3):41-52.
[22] NOÈ A,CAPPELLI B,BIFFI A,et al.High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation:early diagnosis and prompt intervention ameliorates neurological outcome[J].Ital J Pediatr,2010,36:14.
[23] PUSTAVOITAU A,BHARDWAJ A,STEVENS R.Neurological complications of transplantation[J].J Intensive Care Med,2011,26(4):209-222.
[24] MOORMAN M T,EPSTEIN R B,SMITH J W,et al.Management of cyclosporine overdose in a hematopoietic stem cell transplant patient with sequential plasma exchange and red blood cell exchange[J].J Clin Apher,2011,26(3):156-158.
[25] AVIVI I,CHAKRABARTI S,KOTTARIDIS P,et al.Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation[J].Bone Marrow Transplant,2004,34(2):137-142.
[26] WEST S,KENEDI C.Strategies to prevent the neuropsychiatric side-effects of corticosteroids:a case report and review of the literature[J].Curr Opin Organ Transplant,2014,19(2):201-208.
[27] MILLER A D,BALL A M,BOOKSTAVER P B,et al.Epileptogenic potential of carbapenem agents:mechanism of action,seizure rates,and clinical considerations[J].Pharmacotherapy,2011,31(4):408-423.
[28] FAN G R,YIN Z D,SUN Y,et al.Reversible neurotoxicity of kanamycin on dorsal cochlear nucleus[J].Brain Res,2013,1502:30-46.
[29] von EULER M,AXELSSON G,HELLDÉN A.Differential diagnosis of central nervous system involvement in a patient treated with acyclovir[J].Ther Drug Monit,2013,35(4):417-419.
[30] HELLDÉN A,ODAR-CEDERLÖF I,DIENER P,et al.High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects:an observational study[J].Nephrol Dial Transplant,2003,18(6):1135-1141.
[31] BACIGALUPO A,BOYD A,SLIPPER J,et al.Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients[J].Expert Rev Anti Infect Ther,2012,10(11):1249-1264.
[32] NAJIMA Y,OHASHI K,MIYAZAWA M,et al.Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation[J].Am J Hematol,2009,84(5):298-301.
[33] AISA Y,MORI T,NAKAZATO T,et al.Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation[J].Transpl Infect Dis,2009,11(5):438-441.
[34] CHOI C M,SCHMAIER A H,SNELL M R,et al.Thrombotic microangiopathy in haematopoietic stem cell transplantation:diagnosis and treatment[J].Drugs,2009,69(2):183-198.
[35] LABRADOR J,LÓPEZ-CORRAL L,LÓPEZ-GODINO O,et al.Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus[J].Bone Marrow Transplant,2014,49(5):684-690.
[36] JODELE S,FUKUDA T,VINKS A ,et al.Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy[J].Biol Blood Marrow Transplant,2014,20(4):518-525.
[37] OSHIMA K,KANDA Y,YAMASHITA T,et al.Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation[J].Biol Blood Marrow Transplant,2008,14(10):1100-1107.
[38] RUUTU T,CORRADINI P,GRATWOHL A,et al.Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases:a survey of the European Group for Blood and Marrow Transplantation (EBMT)[J].Bone Marrow Transplant,2005,35(2):121-124.
[39] SUZUKI S,MORI T,MIHARA A,et al.Immune-mediated motor polyneuropathy after hematopoietic stem cell transplantation[J].Bone Marrow Transplant,2007,40(3):289-291.
[40] KRAUS P D,WOLFF D,GRAUER O,et al.Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease[J].PLoS One,2012,7(9):e44922.
[41] GRAUER O,WOLFF D,BERTZ H,et al.Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation:report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease[J].Brain,2010,133(10):2852-2865.
[42] DELIOS A M,ROSENBLUM M,JAKUBOWSKI A A,et al.Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease[J].J Neurooncol,2012,110(2):251-256. |
